AI assistant
Applied Therapeutics, Inc. — Director's Dealing 2024
Mar 18, 2024
34263_dirs_2024-03-18_93105b4d-9f92-443c-a593-3850b9524b72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-03-14
Reporting Person: Funtleyder Leslie D. (Director, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-14 | Common Stock | S | 28727.0000 | $5.3900 | Disposed | 308421.0000 | Direct |
Footnotes
F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F2: Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.37 to $5.7855, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.